Activation of kappa Opioid Receptors in Cutaneous Nerve Endings by Conorphin-1, a Novel Subtype-Selective Conopeptide, Does Not Mediate Peripheral Analgesia

作者：Deuis Jennifer R; Whately Ella; Brust Andreas; Inserra Marco C; Asvadi Naghmeh H; Lewis Richard J; Alewood Paul F; Cabot Peter J; Vetter Irma^*

来源：ACS Chemical Neuroscience, 2015, 6(10): 1751-1758.

DOI：10.1021/acschemneuro.5b00113

• kappa opioid receptor
• U-50488
• peripheral
• conorphin-1
• analgesia
• pain

Selective activation of peripheral kappa opioid receptors (KORs) may overcome the dose-limiting adverse effects of conventional opioid analgesics. We recently developed a vicinal disulfide-stabilized class of peptides with subnanomolar potency at the KOR The aim of this study was to assess the analgesic effects of one of these peptides, named conorphin-1, in comparison with the prototypical KOR-selective small molecule agonist U-50488, in several rodent pain models. Surprisingly, neither conorphin-1 nor U-50488 were analgesic when delivered peripherally by intraplantar injection at local concentrations expected to fully activate the KOR at cutaneous nerve endings. While U-50488 was analgesic when delivered at high local concentrations, this effect could not be reversed by coadministration with the selective KOR antagonist ML190 or the nonselective opioid antagonist naloxone. Instead, U-50488 likely mediated its peripheral analgesic effect through nonselective inhibition of voltage-gated sodium channels, including peripheral sensory neuron isoforms Na(v)1.8 and Na(v)1.7. Our study suggests that targeting the KOR in peripheral sensory nerve endings innervating the skin is not an alternative analgesic approach.

• 出版日期2015-10